Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the firstline treatment of metastatic colorectal cancer

Author:                  

Publisher: Spandidos Publications

ISSN: 2049-9469

Source: Molecular and Clinical Oncology, Vol.2, Iss.1, 2014-01, pp. : 166-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content